Neutrophil Functions of Patients With Vasculitis Related to Myeloperoxidase-Specific Anti-Neutrophil Antibody

被引:0
|
作者
Kazuo Suzuki
机构
[1] National Institute of Infectious Diseases (NIID-NIH),Laboratory of Biodefense
[2] National Institute of Infectious Diseases (NIID-NIH),Laboratory of Biodefense
来源
International Journal of Hematology | 2001年 / 74卷
关键词
Activated neutrophils; Vasculitis; Myeloperoxidase; Anti-neutrophil cytoplasmic antibody; MPO-ANCA;
D O I
暂无
中图分类号
学科分类号
摘要
Neutrophils are hypothesized to cause tissue damage resulting in the development of vasculitis and glomerulonephritis, although they are known to primarily take part in host defense functions. The infiltration of inflammatory cells, notably neu-trophils and macrophages, is observed in the progression of vasculitis. Neutrophils with activated status and anti-neutrophil cytoplasmic antibodies (ANCAs), especially myeloperoxidase-specific (MPO)-ANCA, have been implicated in the development of vasculitis. The target molecule of MPO-ANCA is a lysosomal enzyme MPO that usually acts to kill bacteria, viruses, and fungi and that causes damage to the tissue due to the toxicity of its product, hypochlorite (OCl-). To elucidate the role of MPO-ANCA in the progression of vasculitis, a set of MPO-peptide fragments has been developed, and the corresponding epi-tope site for the specific monoclonal and/or oligoclonal antibody resulting in vasculitis has been determined. Recently, some mouse models have been used for analyzing the correlation between MPO and MPO-ANCA in relation to damage of blood vessels followed by the development of vasculitis. This review focuses on the role of activated neutrophils in the development of vasculitis associated with MPO-ANCA and the target molecules of ANCA. In addition, the reactivities of ANCA and inflammatory cytokines involving leukocyte-derived chemotaxin 2 (LECT2) are also discussed.
引用
收藏
页码:134 / 143
页数:9
相关论文
共 50 条
  • [41] Vasculitis of Anti-Neutrophil Cytoplasmic Antibody After Liver Transplantation
    Chen, Hong
    Fan, Tieyan
    Wang, Xu
    Li, Jun
    Niu, Yujian
    Shen, ZhongYang
    JOURNAL OF CRANIOFACIAL SURGERY, 2014, 25 (01) : E76 - +
  • [42] Autoantibodies in anti-neutrophil cytoplasm antibody-associated vasculitis
    Salama, Alan D.
    Rees, Andrew J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (06) : 1105 - 1107
  • [43] Infectious complications of immunosuppressive treatment for anti-neutrophil cytoplasm antibody-related vasculitis
    Koselj-Kajtna, M
    Koselj, M
    Rott, T
    Kandus, A
    Bren, A
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) : 3001 - 3002
  • [44] Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study
    Kim, Sun Moon
    Choi, Song-Yi
    Kim, Seon Young
    Kim, Jinhyun
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (11) : 1919 - 1926
  • [45] High anti-neutrophil cytoplasmic antibody titers are associated with the requirement of permanent dialysis in patients with myeloperoxidase-ANCA-associated vasculitis
    Yen, Chieh-Li
    Tian, Ya-Chung
    Wu, Hsin-Hsu
    Tu, Kun-Hua
    Liu, Shou-Hsuan
    Lee, Cheng-Chia
    Fang, Ji-Tseng
    Yang, Chih-Wei
    Li, Yi-Jung
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (10) : 1408 - 1415
  • [46] The clinical significance of circulating follicular helper T cells in patients with anti-neutrophil cytoplasmic myeloperoxidase antibody-associated vasculitis
    王森
    ChinaMedicalAbstracts(InternalMedicine), 2018, 35 (04) : 209 - 209
  • [47] Should proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibody vasculitis be treated differently: part 2
    Tervaert, Jan Willem Cohen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (03) : 384 - 387
  • [48] Should proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibody vasculitis be treated differently: part 1
    Watts, Richard A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (03) : 381 - 383
  • [49] Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study
    Sun Moon Kim
    Song-Yi Choi
    Seon Young Kim
    Jinhyun Kim
    Rheumatology International, 2019, 39 : 1919 - 1926
  • [50] Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis
    Cornec, Divi
    Kabat, Brian F.
    Mills, John R.
    Cheu, Melissa
    Hummel, Amber M.
    Schroeder, Darrell R.
    Cascino, Matthew D.
    Brunetta, Paul
    Murray, David L.
    Snyder, Melissa R.
    Fervenza, Fernando
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    Langford, Carol A.
    Merkel, Peter A.
    Monach, Paul A.
    Seo, Philip
    Spiera, Robert F.
    St Clair, E. William
    Stone, John H.
    Barnidge, David R.
    Specks, Ulrich
    RHEUMATOLOGY, 2018, 57 (04) : 639 - 650